The Recent Development of 7 Nicotinic Acetylcholine Receptor (nAChR) Ligands as Therapeutic Candidates for the Treatment of Central Nervous System (CNS) Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|14|2134-2151

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.14, 2016-04, pp. : 2134-2151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ligands of Neuronal Nicotinic Acetylcholine Receptor (nAChR): Inferences from the Hansch and 3-D Quantitative Structure-Activity Relationship (QSAR) Models

By  

Current Medicinal Chemistry, Vol. 9, Iss. 1, 2002-01 ,pp. : 1-29

Bentham Science Publishers

Access to resources Recommend Favorite

Concluding Notes of Special Issue “α-7 Nicotinic Receptor (α7-nAChR): One Target Different Diseases”

By  

Current Drug Targets, Vol. 13, Iss. 5, 2012-05 ,pp. : 726-727

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: α7-Nicotinic Receptor (α7-nAChR): One Target Different Diseases (Guest Editors: Patrizia Russo, Alfredo Cesario and Alessio Cardinale)]

By  

Current Drug Targets, Vol. 13, Iss. 5, 2012-05 ,pp. : 573-573

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in the Development of Subtype Selective Nicotinic Acetylcholine Receptor Ligands

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 4, 2002-08 ,pp. : 337-348

Bentham Science Publishers

Access to resources Recommend Favorite

Alpha7 Neuronal Nicotinic Receptor: A Pluripotent Target for Diseases of the Central Nervous System

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 5, 2014-06 ,pp. : 836-845

Bentham Science Publishers

Access to resources Recommend Favorite